Smith & Nephew plc

NYSE:SNN

Medical - Devices

Healthcare
$30.32 -1.39%

-$0.43 today

Market cap
$12.72B
Beta
0.67
P/E (TTM)
20.1
EPS (TTM)
$0.74
Dividend yield
2.59%
52W Low $28.79High $38.79

Volume 1.22M

Average 1.10M

SNN Deferred Tax Liabilities

Taxes owed in future periods because of timing differences between accounting and tax rules.

Smith & Nephew plcNYSE: SNN

Deferred Tax Liabilities · Q4 FY2025 · quarter ended Dec 2025

Deferred tax liabilities rises 29.0% from a year ago

Deferred tax liabilities stood at $40M at the end of Q4 FY2025, up 29.0% from a year earlier. Over 3 fiscal years it compounded at +3.6% a year.

Context

  • Deferred tax liabilities amounted to 0.4% of total assets at the end of Q4 FY2025, unchanged from a year earlier.
  • Deferred tax liabilities increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred tax liabilities keeps rising in the next quarterly balance sheet after a +29.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$40M— QoQ
Last fiscal yearDec 2025
$40M+29.0% YoY
Year agoDec 2024
$31M+29.0% since
Deferred Tax Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+29.0%——
1 year+29.0%——
3-year CAGR+3.6%——
5-year CAGR——
10-year CAGR——

Deferred Tax Liabilities history

USD · from the balance sheet

Latest · FY2025
40M USD
Year-over-year change
+29.0%
4-year CAGR
-27.4%

Deferred Tax Liabilities vs competitors

How SNN compares with its peers on the latest reported figures

  • SNN's Dec 2025 deferred tax liabilities of $40M is the 4th highest of the 11 companies compared; the peer median is $1.68M.
  • Its year-over-year change of +29.0% is the 2nd highest of 6, against a peer median of -1.0%.
  • Deferred tax liabilities amounts to 0.4% of total assets for SNN, versus a peer median of 0.1%.
SNN Competitors Peer median
Deferred Tax Liabilities for SNN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ZBHZimmer Biomet Holdings, Inc.Jun 2026$235.6M —-19.9%1.0%
CNMDCONMED CorporationMar 2026$81.38M +16.3%+6.0%3.5%
GMEDGlobus Medical, Inc.Jun 2026$42.34M +73.5%+137.2%0.8%
SNNSmith & Nephew plcDec 2025$40M +29.0%+3.6%0.4%
IARTIntegra LifeSciences Holdings CorporationMar 2026$6.14M -89.3%-55.3%0.2%
KIDSOrthoPediatrics Corp.Mar 2026$3.36M -1.0%-15.6%0.7%
SYKStryker CorporationJun 2026$0 —+26.9%0.0%
ENOVEnovis CorporationApr 2026$0 ——0.0%
ATECAlphatec Holdings, Inc.Mar 2026$0 ——0.0%
OFIXOrthofix Medical Inc.Mar 2026$0 ——0.0%
XTNTXtant Medical Holdings, Inc.Mar 2026$0 -100.0%—0.0%
Peer median (excluding SNN) $1.68M-1.0%-4.8%0.1%

Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.29B350M302M619M557M
Short-term Investments00000
Net Receivables971M1.03B1.06B1.21B1.43B
Inventory1.84B2.21B2.4B2.39B2.12B
Other Current Assets240M198M182M81M(99M)
Total Current Assets4.42B3.86B4.03B4.42B4.1B
Property, Plant & Equipment (Net)1.51B1.46B1.47B1.42B1.64B
Goodwill2.99B3.03B2.99B3.03B3.11B
Intangible Assets1.4B1.24B1.11B1.03B882M
Long-term Investments380M58M24M16M151M
Tax Assets201M177M274M334M347M
Other Non-current Assets15M153M87M103M228M
Total Non-current Assets6.5B6.11B5.96B5.93B6.35B
Total Assets10.92B9.97B9.99B10.35B10.46B
Account Payables1.04B1.03B1.02B1.08B1.16B
Short-term Debt435M111M710M2M83M
Tax Payables222M214M218M232M0
Deferred Revenue00000
Other Current Liabilities597M526M261M126M85M
Total Current Liabilities2.13B1.72B2.27B1.53B1.6B
Long-term Debt2.71B2.57B2.18B3.12B3.03B
Deferred Tax Liabilities144M36M9M31M40M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities229M244M171M269M356M
Total Non-current Liabilities3.22B2.99B2.5B3.56B3.57B
Total Liabilities5.35B4.71B4.77B5.09B5.17B
Common Stock177M175M175M175M175M
Retained Earnings5.23B5.03B4.91B5.02B5.32B
Accumulated OCI(328M)(439M)(385M)020M
Other Stockholders Equity000(497M)(329M)
Minority Interest00000
Total Equity5.57B5.26B5.22B5.27B5.29B
Total Debt3.34B2.87B3.08B3.32B3.33B
Net Debt2.05B2.52B2.78B2.7B2.77B

Smith & Nephew plc

NYSE:SNN

Intrinsic Alpha fair value

Locked

Current Price

$30.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.